Akero Therapeutics Inc. (NASDAQ:AKRO)
Old Forum Content for AKRO
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- Roadrunner: $AKRO up 100% Akero soars as drug shows it reverses scarring in liver disease patients in mid stage trial
- woodman: @Roadrunner $AKRO - Wow!
- woodman: $AKRO - filling a huge gap. I've not followed this one in the NASH/liver therapeutic area and don't have a position.
- woodman: @mhuie $ETNB - Nice move off the bottom as it is rapidly moving to test that gap from the drop on 10/10. My sense is that many in the obesity space - and related Diabetes/liver/NASH & cardio spaces - are moving on good industry-wide obesity data ...
- shoredriver: $AKRO....rolling bio dumpster fire du jour..np..
- woodman: $TERN is next up (Q3) in the NASH therapeutic area (TA) - for its Phase 2a top line data for TERN-501 (THR-B Agonist) alone and in combo with TERN-101 (FXR Agonist) (DUET trial). Other bios focusing on NASH ($AKRO $MDGL $ETNB $VKTX) have moved well post-NASH-data reporting.
- marklesparkle: @woodman $VKTX $ETNB $MDGL $AKRO is another NASH which I just got shaken out of today for small profit even as I'm saying theres nothing wrong with it. But not afraid to jump back in on a PB now
- fiebs: $AKRO Anyone see news as to why it is down 22% pre-market?
- traderdl: @fiebs $AKRO $MDGL news
- natural: Just an FYI, if you, like me, are struggling a bit in this insane market - you are not alone. Check the charts on these stocks. "Lots of biotech stocks emerging even before the market made the recent low. We added $AKRO back in September and it worked well. We currently own names such as $NBIX, $CORT and $REGN. $PRTA is trying to emerge now after a 1-day shakeout with a good close a few days ago." - investing legend, Mark Minervini, via Twitter, on Nov 1.
-
DAN: ...
$AKRO -- (From 9/16 - Huge power move. ONLY buy at a new high. Alert $30). Alert fired off today. Up 14%. If you didn’t act on the alert, you’ve gotta wait.
$AZPN -- Never pulled back. Very thin. Watch volume. Prior resistance at ... -
DAN: ...
$AKRO -- Huge power move. ONLY buy at a new high. Alert $30
$AZPN -- Wait for 50-day MA before considering.Alert $230
$VRTX -- Alert $300
$XENE -- Alert $39.70
- grcjr: $AKRO up more than a double today. Spotted this in a scan I do. Not a company I have any knowledge of. We used to have a member who did fantastic reviews of medical family. Akero Therapeutics Shares Soar Pre-Bell on Efruxifermin Phase 2b Study Meeting Endpoints for NASH Treatment MT NEWSWIRES 7:06 AM ET 9/13/2022
- Mikev200: $AKRO moving , vol pop
- Mikev200: $AKRO HOD
- Mikev200: $AKRO hod also after close. Akero Therapeutics to Announce New Data from an Evaluation of Efruxifermin (EFX) in Cirrhotic NASH (F4) Patients
- Mikev200: $AKRO HOD maybe some ppl "know" what's in this phase 3 report after close.
- bRobert: $AKRO Threatening
| Stock Price | $54.65 |
| Change | 0.00% |
| Volume | 15,308,800 |
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate AKR-001 is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
Request Video of AKROAlready a member? Sign in here.
Past Month
Leading Peers
-
$27.34 159.64%
-
$26.72 112.67%
-
$21.37 111.04%
Past Month
Lagging Peers
-
$15.74 -55.57%
-
$6.21 -54.75%
-
$6.22 -49.14%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!